Skip to main content

Advertisement

Log in

Genetic susceptibility to cervical squamous cell carcinoma is associated with HLA-DPB1 polymorphisms in Taiwanese women

  • Original Article
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Abstract

Cervical cancer is a multifactorial disease, and increasing evidence suggests that host immunogenetic background may contribute to its pathogenesis. Genetic variations in human leukocyte antigen (HLA) genes may alter the efficiency of immune response to human papillomavirus (HPV) antigens and have been implicated in the risk of cervical cancer. We investigated whether polymorphisms in the HLA-DPB1 gene were associated with cervical cancer risk in a Taiwanese population. HLA-DPB1 alleles and +550 G/A polymorphism were genotyped in a case–control study of 473 women with cervical squamous cell carcinoma (CSCC) and 676 healthy controls. The presence and genotypes of HPV in CSCC were determined. We found that the DPB1*05:01 and +550 A alleles were associated with decreased and increased risk of CSCC, respectively [odds ratio (OR) = 0.72, P c = 0.001; OR = 1.25, P c = 0.03]. In subgroup analysis based on HPV type 16 positivity, significant associations were shown in the DPB1*05:01 and *13:01 alleles (OR = 0.65, P c = 0.0007; OR = 1.83, P c = 0.004). Furthermore, the DPB1*05:01-G and *13:01-G haplotypes conferred decreased and increased risk of both CSCC and HPV-16 positive CSCC women, respectively (OR = 0.72, P c = 0.0009; OR = 0.63, P c = 0.0004 for DPB1*05:01-G; OR = 1.55, P c = 0.03; OR = 1.84, P c = 0.004 for DPB1*13:01-G). A risk haplotype DPB1*02:01-A was also observed in the HPV-16 positive CSCC women (OR = 1.51, P c = 0.05). These findings suggest that HLA-DPB1 gene is involved in the CSCC development.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

CI:

Confidence interval

CSCC:

Cervical squamous cell carcinoma

HLA:

Human leukocyte antigen

HPV:

Human papillomavirus

LD:

Linkage disequilibrium

OR:

Odds ratio

PCR:

Polymerase chain reaction

References

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90

    Article  PubMed  Google Scholar 

  2. Chen CA, Hsieh CY (2004) Recent advances and problems in primary therapy for cervical cancer in Taiwan. J Formos Med Assoc 103:511–518

    PubMed  Google Scholar 

  3. Munoz N (2000) Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 19:1–5

    Article  CAS  PubMed  Google Scholar 

  4. Magnusson PK, Sparen P, Gyllensten UB (1999) Genetic link to cervical tumours. Nature 400:29–30

    Article  CAS  PubMed  Google Scholar 

  5. Hildesheim A, Wang SS (2002) Host and viral genetics and risk of cervical cancer: a review. Virus Res 89:229–240

    Article  CAS  PubMed  Google Scholar 

  6. Madeleine MM, Johnson LG, Smith AG, Hansen JA, Nisperos BB, Li S, Zhao LP, Daling JR, Schwartz SM, Galloway DA (2008) Comprehensive analysis of HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 loci and squamous cell cervical cancer risk. Cancer Res 68:3532–3539

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  7. Chan DP, Cheung TH, Tam AO, Cheung JL, Yim SF, Lo KW, Siu NS, Zhou DX, Chan PK (2005) Risk association between human leukocyte antigen-A allele and high-risk human papillomavirus infection for cervical neoplasia in Chinese women. J Infect Dis 192:1749–1756

    Article  CAS  PubMed  Google Scholar 

  8. Wang SS, Hildesheim A, Gao X, Schiffman M, Herrero R, Bratti MC, Sherman ME, Barnes WA, Greenberg MD, McGowan L, Mortel R, Schwartz PE, Zaino RJ, Glass AG, Burk RD, Karacki P, Carrington M (2002) Comprehensive analysis of human leukocyte antigen class I alleles and cervical neoplasia in 3 epidemiologic studies. J Infect Dis 186:598–605

    Article  CAS  PubMed  Google Scholar 

  9. Schiff MA, Apple RJ, Lin P, Nelson JL, Wheeler CM, Becker TM (2005) HLA alleles and risk of cervical intraepithelial neoplasia among southwestern American Indian women. Hum Immunol 66:1050–1056

    Article  CAS  PubMed  Google Scholar 

  10. Wu Y, Liu B, Lin W, Xu Y, Li L, Zhang Y, Chen S, Lin Z, Xu A (2007) Human leukocyte antigen class II alleles and risk of cervical cancer in China. Hum Immunol 68:192–200

    Article  CAS  PubMed  Google Scholar 

  11. Liang J, Xu A, Xie Y, Awonuga AO, Lin Z (2008) Some but not all of HLA-II alleles are associated with cervical cancer in Chinese women. Cancer Genet Cytogenet 187:95–100

    Article  CAS  PubMed  Google Scholar 

  12. O’Brien TR, Kohaar I, Pfeiffer RM, Maeder D, Yeager M, Schadt EE, Prokunina-Olsson L (2011) Risk alleles for chronic hepatitis B are associated with decreased mRNA expression of HLA-DPA1 and HLA-DPB1 in normal human liver. Genes Immun 12:428–433

    Article  PubMed Central  PubMed  Google Scholar 

  13. Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greer CE, Zhang T, Scott DR, Rush BB, Lawler P, Sherman ME et al (1994) Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 169:235–240

    Article  CAS  PubMed  Google Scholar 

  14. de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ (1995) The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76(Pt 4):1057–1062

    Article  PubMed  Google Scholar 

  15. van der Zwan AW, Rozemuller E, Tilanus MG (2006) Sequencing based typing for HLA-DPB1: Strategy for ABI equipment. In: Hansen JA (ed) Immunobiology of the human MHC. Proceedings of the 13th international histocompatibility workshop and conference. IHWG Press, Seattle, pp 374–375

  16. Chu CC, Trejaut J, Lee HL, Lin M (2006) Anthropology/human genetic diversity population reports: Taiwan’s populations. In: Hansen JA (ed) Immunobiology of the human MHC. Proceedings of the 13th international histocompatibility workshop and conference. IHWG Press, Seattle, pp 611–615

  17. Meyer D, Single RM, Mack SJ, Lancaster A, Nelson MP, Erlich H, Fernandez-Vina M, Thomson G (2006) Single locus polymorphism of classical HLA genes. In: Hansen JA (ed) Immunobiology of the human MHC. Proceedings of the 13th international histocompatibility workshop and conference. IHWG Press, Seattle, pp 653–704

  18. Lancaster AK, Single RM, Solberg OD, Nelson MP, Thomson G (2007) PyPop update—a software pipeline for large-scale multilocus population genomics. Tissue Antigens 69(Suppl 1):192–197

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. Guo SW, Thompson EA (1992) Performing the exact test of Hardy–Weinberg proportion for multiple alleles. Biometrics 48:361–372

    Article  CAS  PubMed  Google Scholar 

  20. Svejgaard A, Ryder LP (1994) HLA and disease associations: detecting the strongest association. Tissue Antigens 43:18–27

    Article  CAS  PubMed  Google Scholar 

  21. Ohashi J, Yamamoto S, Tsuchiya N, Hatta Y, Komata T, Matsushita M, Tokunaga K (2001) Comparison of statistical power between 2 * 2 allele frequency and allele positivity tables in case–control studies of complex disease genes. Ann Hum Genet 65:197–206

    Article  CAS  PubMed  Google Scholar 

  22. Chen YY, You SL, Chen CA, Shih LY, Koong SL, Chao KY, Hsiao ML, Hsieh CY, Chen CJ (2009) Effectiveness of national cervical cancer screening programme in Taiwan: 12-year experiences. Br J Cancer 101:174–177

    Article  PubMed Central  PubMed  Google Scholar 

  23. Beskow AH, Josefsson AM, Gyllensten UB (2001) HLA class II alleles associated with infection by HPV16 in cervical cancer in situ. Int J Cancer 93:817–822

    Article  CAS  PubMed  Google Scholar 

  24. Beskow AH, Gyllensten UB (2002) Host genetic control of HPV 16 titer in carcinoma in situ of the cervix uteri. Int J Cancer 101:526–531

    Article  CAS  PubMed  Google Scholar 

  25. Beskow AH, Moberg M, Gyllensten UB (2005) HLA class II allele control of HPV load in carcinoma in situ of the cervix uteri. Int J Cancer 117:510–514

    Article  CAS  PubMed  Google Scholar 

  26. Chuang LC, Hu CY, Chen HC, Lin PJ, Lee B, Lin CY, Pan MH, You SL, Hsieh CY, Chen CJ (2012) Associations of human leukocyte antigen class II genotypes with human papillomavirus 18 infection and cervical intraepithelial neoplasia risk. Cancer 118:223–231

    Article  CAS  PubMed  Google Scholar 

  27. Edwards JA, Durant BM, Jones DB, Evans PR, Smith JL (1986) Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression. J Immunol 137:490–497

    CAS  PubMed  Google Scholar 

  28. Kamatani Y, Wattanapokayakit S, Ochi H, Kawaguchi T, Takahashi A, Hosono N, Kubo M, Tsunoda T, Kamatani N, Kumada H, Puseenam A, Sura T, Daigo Y, Chayama K, Chantratita W, Nakamura Y, Matsuda K (2009) A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet 41:591–595

    Article  CAS  PubMed  Google Scholar 

  29. Mbarek H, Ochi H, Urabe Y, Kumar V, Kubo M, Hosono N, Takahashi A, Kamatani Y, Miki D, Abe H, Tsunoda T, Kamatani N, Chayama K, Nakamura Y, Matsuda K (2011) A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population. Hum Mol Genet 20:3884–3892

    Article  CAS  PubMed  Google Scholar 

  30. Nishida N, Sawai H, Matsuura K, Sugiyama M, Ahn SH, Park JY, Hige S, Kang JH, Suzuki K, Kurosaki M, Asahina Y, Mochida S, Watanabe M, Tanaka E, Honda M, Kaneko S, Orito E, Itoh Y, Mita E, Tamori A, Murawaki Y, Hiasa Y, Sakaida I, Korenaga M, Hino K, Ide T, Kawashima M, Mawatari Y, Sageshima M, Ogasawara Y, Koike A, Izumi N, Han KH, Tanaka Y, Tokunaga K, Mizokami M (2012) Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean. PLoS One 7:e39175

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  31. Guo X, Zhang Y, Li J, Ma J, Wei Z, Tan W, O’Brien SJ (2011) Strong influence of human leukocyte antigen (HLA)-DP gene variants on development of persistent chronic hepatitis B virus carriers in the Han Chinese population. Hepatology 53:422–428

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  32. Wang L, Wu XP, Zhang W, Zhu DH, Wang Y, Li YP, Tian Y, Li RC, Li Z, Zhu X, Li JH, Cai J, Liu L, Miao XP, Liu Y, Li H (2011) Evaluation of genetic susceptibility loci for chronic hepatitis B in Chinese: two independent case–control studies. PLoS ONE 6:e17608

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  33. Li J, Yang D, He Y, Wang M, Wen Z, Liu L, Yao J, Matsuda K, Nakamura Y, Yu J, Jiang X, Sun S, Liu Q, Song Q, Chen M, Yang H, Tang F, Hu X, Wang J, Chang Y, He X, Chen Y, Lin J (2011) Associations of HLA-DP variants with hepatitis B virus infection in southern and northern Han Chinese populations: a multicenter case–control study. PLoS One 6:e24221

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  34. Hu L, Zhai X, Liu J, Chu M, Pan S, Jiang J, Zhang Y, Wang H, Chen J, Shen H, Hu Z (2012) Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development. Hepatology 55:1426–1431

    Article  CAS  PubMed  Google Scholar 

  35. Al-Qahtani AA, Al-Anazi MR, Abdo AA, Sanai FM, Al-Hamoudi W, Alswat KA, Al-Ashgar HI, Khalaf NZ, Eldali AM, Viswan NA, Al-Ahdal MN (2014) Association between HLA variations and chronic hepatitis B virus infection in Saudi Arabian patients. PLoS One 9:e80445

    Article  PubMed Central  PubMed  Google Scholar 

  36. Jiang J, Li N, Shen Y, Liu J, Liu L, Du J, Lei Y, Wen Y, Yang L, Guo L, Zhang K, Qiang F, Wang S, Hu Z, Dai M, Shen H (2013) Genetic variants in HLA-DP/DQ contribute to risk of cervical cancer: a two-stage study in Chinese women. Gynecol Oncol 129:401–405

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This research was supported by Grants MMH 9781 and MMH E-103-07 from Mackay Memorial Hospital, Taiwan.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yann-Jinn Lee.

Additional information

Yuh-Cheng Yang and Tzu-Yang Chang have contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yang, YC., Chang, TY., Chen, TC. et al. Genetic susceptibility to cervical squamous cell carcinoma is associated with HLA-DPB1 polymorphisms in Taiwanese women. Cancer Immunol Immunother 64, 1151–1157 (2015). https://doi.org/10.1007/s00262-015-1721-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00262-015-1721-5

Keywords

Navigation